StockClub

EPGNF

EPGNFEpigenomics AG$ --
Epigenomics AG

Epigenomics AG

EPGNF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2023FY2023 Q4
Revenue
0M EUR
YoY -32.2%
Operating Income
2M EUR
YoY +129.9%
Net Income
2M EUR
YoY +128.9%
EPS
2.2EUR
YoY +127.7%

Revenue

EUR339,227
FY2022 Q1EUR115,000
EUR115,000
Q1
FY2022 Q2EUR241,000
EUR241,000
Q2
FY2022 Q3EUR386,000
EUR386,000
Q3
FY2022 Q4EUR485,000
EUR485,000
Q4
FY2023 Q1EUR134,000
EUR134,000
Q1
FY2023 Q2EUR204,000
EUR204,000
Q2
FY2023 Q3EUR272,114
EUR272,114
Q3
FY2023 Q4EUR339,227
EUR339,227
Q4
Actual
EUR-145,773 (-30.1%)

Net Income

EUR-4.5M
FY2022 Q1EUR-2.7M
EUR-2.7M
Q1
FY2022 Q2EUR-4M
EUR-4M
Q2
FY2022 Q3EUR-5.5M
EUR-5.5M
Q3
FY2022 Q4EUR-12M
EUR-12M
Q4
FY2023 Q1EUR-5.6M
EUR-5.6M
Q1
FY2023 Q2EUR-8.2M
EUR-8.2M
Q2
FY2023 Q3EUR-6.3M
EUR-6.3M
Q3
FY2023 Q4EUR-4.5M
EUR-4.5M
Q4
Actual
+EUR7.6M (+62.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:EUR842,000
Est:EUR784,295
FY2020BEAT
EUR842,000
FY2021MISS
Actual:EUR6.2M
Est:EUR7M
FY2021MISS
EUR6.2M
FY2022MISS
Actual:EUR485,000
Est:EUR802,687
FY2022MISS
EUR485,000
FY2023MISS
Actual:EUR339,227
Est:EUR1.8M
FY2023MISS
EUR339,227
FY2024MISS
Actual:EUR0
Est:EUR299,913
FY2024MISS
EUR0
FY2025IN-LINE
Actual:EUR23,990
Est:EUR23,990
FY2025IN-LINE
EUR23,990

Analyst Estimates